Indivior's Chief Scientific Officer Stock Sale: Worry?
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
It's never too early to think about retirement. Learn when to start planning for your retirement and ensure financial stability.
26,408 articlesA large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
In 2025, Tim Cook and Reed Hastings stepped back from the helm with quiet discipline, delivering a leadership playboo...
A wave of resignations among junior ministers tests Keir Starmer’s leadership after local election losses. The evolvi...
Inflation fuels expectations for a sizable 2027 COLA. If the projection holds, social security retirees looking ahead...
Qualcomm sits at the intersection of phones, cars, and AI tech. This guide breaks down what qualcomm stock investors ...
As Oklo enters 2026, the Q1 earnings landscape offers clues about its path to commercialization. This guide breaks do...
An AI investment story built on Nvidia backing and a defense tech tie-up is gaining attention. This article breaks do...
Bitcoin's recent surge has sparked talk of a new bull leg. Yet Wintermute's warning — wintermute cautions 'relief ral...
Archer’s Q1 2026 numbers set the tone for the year. This article breaks down the earnings call, explains what really ...
A sharp one-day drop in ZoomInfo’s shares has investors weighing growth against profitability. This analysis explains...
A trio of blue-chip dividend payers is delivering double-digit gains and reliable income for retirees as 2026 unfolds...